These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8769043)

  • 1. Reducing prescribing.
    Harris J; Bennett W
    N Z Med J; 1996 Jun; 109(1024):243. PubMed ID: 8769043
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost of pharmaceutical benefits.
    Mackereth MB
    N Z Med J; 1988 Jul; 101(849):460-1. PubMed ID: 3399187
    [No Abstract]   [Full Text] [Related]  

  • 3. How many antibiotic prescriptions are unsubsidised in New Zealand?
    Norris P; Funke S; Becket G; Ecke D; Reiter L; Herbison P
    N Z Med J; 2006 May; 119(1233):U1951. PubMed ID: 16680168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-prescribing and Part D drugs.
    Davino MM
    Med Econ; 2006 Feb; 83(3):26. PubMed ID: 16506623
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in prescribing--the dawn of DUSC.
    Med J Aust; 1990 May; 152(9):504. PubMed ID: 2381352
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives. E-prescribing, formularies play big roles in Rx bill. 2.
    Med Health; 2003 Dec; 57(45):1, 7-8. PubMed ID: 14723167
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 8. 24th annual prescription survey, Albany College of Pharmacy.
    DeNuzzo RV
    Med Mark Media; 1980 Apr; 15(4):17-36. PubMed ID: 10245963
    [No Abstract]   [Full Text] [Related]  

  • 9. Paying for prescriptions: programs that can help.
    Pa Med; 2001; 104(1):7. PubMed ID: 11197143
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescribing data and cost comparisons in New Zealand.
    Bishop N; Maling T
    N Z Med J; 1997 Nov; 110(1056):445-6. PubMed ID: 9418844
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry warily eyes new Medicare drug plan.
    Vastag B
    Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing costs.
    Lexchin J
    N Z Med J; 1988 Sep; 101(854):616. PubMed ID: 3173867
    [No Abstract]   [Full Text] [Related]  

  • 13. Variability within general practitioner prescribing over time.
    Bishop N; Maling T
    N Z Med J; 2000 Jan; 113(1102):14-6. PubMed ID: 10738495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare Part D: primer.
    Coakley C
    Adv Nurse Pract; 2006 Sep; 14(9):24. PubMed ID: 16972439
    [No Abstract]   [Full Text] [Related]  

  • 15. Catastrophic health insurance: budget and policy issues.
    Helms RB
    Am J Pharm Educ; 1989; 53(4):356-9. PubMed ID: 10304253
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicare coverage of prescription drugs.
    Division of Advocacy and Health Policy
    Bull Am Coll Surg; 2005 Sep; 90(9):29-30, 62. PubMed ID: 18435099
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare and the politics of prescription drug pricing.
    Oberlander J
    N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
    [No Abstract]   [Full Text] [Related]  

  • 18. In Beltway, all eyes are on drug benefit.
    Gardner J
    Mod Healthc; 2000 May; 30(21):44. PubMed ID: 11067548
    [No Abstract]   [Full Text] [Related]  

  • 19. DTCA not real advertising issue.
    Saunders B
    N Z Med J; 2003 Sep; 116(1182):U611. PubMed ID: 14581960
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct-to-consumer advertising--where does the public interest lie?
    Saunders B
    N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.